Hematologic Malignancies
Multiple myeloma is a major area of interest, with studies spanning newly diagnosed disease in patients eligible for autologous stem cell transplantation and in older or transplant-ineligible populations.
- Induction and maintenance strategies in newly diagnosed multiple myeloma
- Treatment approaches for transplant-ineligible myeloma
- Response and progression control in plasma cell disorders
Research activity in this area includes combinations built around proteasome inhibitors, immunomodulatory agents, and anti-CD38 therapy.
Thoracic Oncology
The sponsor funds clinical research in non-small cell lung cancer, including unresectable locally advanced disease and treatment settings centered on chemo-radiotherapy followed by maintenance therapy.
- Non-small cell lung cancer
- Locally advanced unresectable lung cancer
- Maintenance immunotherapy after chemo-radiotherapy
Its thoracic oncology portfolio also reflects interest in immunotherapy and long-term disease control.
Genitourinary Cancers
Another active domain is prostate cancer, including high-risk and oligometastatic presentations managed in relation to radical prostatectomy and postoperative systemic treatment.
- Metastatic prostate cancer
- High-risk prostate cancer
- Urothelial cancer
Research in urothelial carcinoma focuses on maintenance treatment after platinum-based chemotherapy and disease control in advanced settings.
Pleural Malignancies
The sponsor also supports studies in pleural mesothelioma, with attention to biomarker-defined disease and treatment combinations involving targeted therapy and immunotherapy.
- Pleural mesothelioma
- PD-L1-positive disease
- HRR gene-altered tumors
This area reflects interest in advanced thoracic cancers with molecularly selected treatment options.
Critical Care
Beyond oncology, the clinical research portfolio includes critical illness and emergency care, with focus on preventing cardiovascular collapse during endotracheal intubation.
- Critical illness
- Endotracheal intubation
- Vasopressor therapy
These studies are centered on hemodynamic stabilization in acutely ill adults.
